by Matthew Johnson | Dec 18, 2018 | Evidentiary Issues
By Jihong Lou, Levent Herguner, Alex Li, and Matt Johnson – On December 6, 2018, the PTAB hosted a Boardside Chat webinar on hearsay and authentication. The Administrative Patent Judges presenting the webinar were Michael Zecher, Tom Giannetti, and Grace...
by Jennifer Chheda, Ph.D. | Oct 25, 2018 | Evidentiary Issues
By: Jennifer J. Chheda, Ph.D and John D. Kinton The Federal Circuit recently affirmed the Patent Trial and Appeal Board’s (“PTAB”) final written decisions finding the claims of Yeda Research and Development Co., Ltd.’s (“Yeda”) U.S. Patent Nos. 8,232,250, 8,399,413,...
by Gasper LaRosa | Aug 22, 2018 | Evidentiary Issues, Motions Practice, Pharmaceutical
By: Mital B. Patel and Gasper J. LaRosa The PTAB recently granted a rare motion for additional discovery into the question of whether an unnamed party, Amneal Pharmaceuticals, LLC (“Amneal”), should have been named as a real-party-in-interest. In Kashiv LLC v. Purdue...
by Carl Kukkonen | Aug 22, 2018 | Evidentiary Issues
By: Amanda Leckman and Carl Kukkonen A party to an inter partes review may submit supplemental information within one month of institution if the party can show that the supplemental information is “relevant to a claim for which the trial has been instituted.” 37...
by Doug Pearson | Jun 28, 2018 | Evidentiary Issues, Prior Art Issues
By: Doug Pearson With the universe of prior art available for IPRs being limited to patents and printed publications (35 U.S.C. § 311(b)), questions regarding the applicability of printed material that might be considered less mainstream prior art are sure to arise. ...
by Matthew Johnson | Jun 14, 2018 | Evidentiary Issues
By: Tom Ritchie and Matt Johnson In Ericsson Inc. v. Intellectual Ventures I LLC, No. 2016-1671, 2018 WL 2407172 (Fed. Cir. 2018), a divided panel of the Federal Circuit reversed a PTAB decision that had sustained the patentability of claim 1 of U.S. Patent No....
